Portal de Periódicos da CAPES

Patient Expectations From Implantable Defibrillators to Prevent Death in Heart Failure

2009; Elsevier BV; Volume: 16; Issue: 2 Linguagem: Inglês

10.1016/j.cardfail.2009.09.003

1532-8414

Garrick C. Stewart, Joanne R. Weintraub, Parakash Pratibhu, Marc J. Semigran, Janice Camuso, Kimberly Brooks, Sui Tsang, Mary Susan Anello, Viviane Nguyen, Eldrin F. Lewis, Anju Nohria, Akshay S. Desai, Michael M. Givertz, Lynne W. Stevenson,

Cardiac Arrhythmias and Treatments

Background-Indications for implantable cardioverter-defibrillators (ICDs) in heart failure (HF) are expanding and may include more than 1 million patients.This study examined patient expectations from ICDs for primary prevention of sudden death in HF. Methods and Results-Study participants (n = 105) had an EF <35% and symptomatic HF, without history of ventricular tachycardia/fibrillation or syncope.Subjects completed a written survey about perceived ICD benefits, survival expectations, and circumstances under which they might deactivate defibrillation.Mean age was 58, LVEF 21%, 40% were New York Heart Association Class III-IV, and 65% already had a primary prevention ICD.Most patients anticipated more than10 years survival despite symptomatic HF.Nearly 54% expected an ICD to save ≥50 lives per 100 during 5 years.ICD recipients expressed more confidence that the device would save their own lives compared with those without an ICD (P < .001).Despite understanding the ease of deactivation, 70% of ICD recipients indicated they would keep the ICD on even if dying of cancer, 55% even if having daily shocks, and none would inactivate defibrillation even if suffering constant dyspnea at rest.Conclusions-HF patients anticipate long survival, overestimate survival benefits conferred by ICDs, and express reluctance to deactivate their devices even for end-stage disease.